HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cynthia M Magro Selected Research

Organ Transplantation

12/2018Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
6/2003The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cynthia M Magro Research Topics

Disease

17Neoplasms (Cancer)
10/2017 - 09/2003
14Lymphoma (Lymphomas)
11/2023 - 07/2006
10Vasculitis (Vasculitides)
11/2022 - 06/2002
8Dermatomyositis (Dermatopolymyositis)
11/2023 - 02/2003
7Infections
01/2024 - 01/2003
7Fibrosis (Cirrhosis)
04/2023 - 01/2004
7Inflammation (Inflammations)
12/2022 - 04/2006
6COVID-19
10/2023 - 06/2020
6Vascular System Injuries
04/2023 - 11/2002
6Malignant Atrophic Papulosis
04/2023 - 11/2002
6Disease Progression
12/2019 - 11/2002
6Vascular Diseases (Vascular Disease)
02/2019 - 02/2007
6Skin Diseases (Skin Disease)
01/2017 - 08/2007
5Melanoma (Melanoma, Malignant)
12/2023 - 10/2005
5Purpura
11/2022 - 11/2002
5Erythema elevatum diutinum
11/2022 - 11/2002
5Thrombosis (Thrombus)
01/2021 - 11/2013
5Idiopathic Pulmonary Fibrosis
06/2014 - 11/2002
5Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2014 - 02/2003
5Necrosis
10/2013 - 11/2002
5Rheumatoid Arthritis
08/2011 - 02/2003
4Mycosis Fungoides
11/2023 - 09/2015
4B-Cell Lymphoma (Lymphoma, B Cell)
12/2018 - 08/2005
4Nevus (Nevi)
06/2017 - 03/2010
4Hypersensitivity (Allergy)
07/2016 - 03/2003
4Dermatitis
08/2011 - 06/2002
4Hemorrhage
04/2009 - 11/2002
4Connective Tissue Diseases (Connective Tissue Disease)
01/2008 - 06/2002
3T-Cell Lymphoma (Lymphoma, T Cell)
02/2024 - 05/2015
3Panniculitis
02/2024 - 04/2008
3Lupus Erythematosus Panniculitis (Panniculitis, Lupus)
02/2024 - 09/2012
3Psoriasis (Pustulosis Palmaris et Plantaris)
11/2023 - 05/2010
3Diabetes Mellitus
04/2023 - 01/2007
3Localized Scleroderma (Morphea)
04/2023 - 03/2011
3Crohn Disease (Crohn's Disease)
01/2023 - 02/2017
3Bullous Pemphigoid (Pemphigoid)
11/2022 - 11/2008
3Pseudolymphoma
07/2018 - 07/2006
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2018 - 03/2003
3Hyperplasia
01/2017 - 02/2003
3Thrombotic Microangiopathies
05/2015 - 11/2013
2Erythema
02/2024 - 01/2008
2Paraproteinemias (Monoclonal Gammopathy)
12/2023 - 10/2012
2Telangiectasis (Telangiectasia)
12/2023 - 05/2022
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2023 - 07/2006
2Atypical Hemolytic Uremic Syndrome
12/2020 - 05/2015
2Amyloidosis
11/2019 - 07/2005
2Alopecia (Baldness)
11/2019 - 12/2011
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2018 - 10/2006
2Carcinoma (Carcinomatosis)
10/2018 - 06/2006
2Polyarteritis Nodosa (Periarteritis Nodosa)
12/2017 - 03/2003
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 09/2006
2Nephrogenic Fibrosing Dermopathy
01/2017 - 09/2008
2Thrombotic Thrombocytopenic Purpura
05/2015 - 01/2015
2Calciphylaxis
01/2015 - 05/2002

Drug/Important Bio-Agent (IBA)

14Complement System Proteins (Complement)IBA
04/2023 - 03/2003
12AntibodiesIBA
11/2023 - 11/2002
11CollagenIBA
02/2019 - 06/2002
10Proteins (Proteins, Gene)FDA Link
12/2023 - 05/2002
10Complement Membrane Attack Complex (Membrane Attack Complex)IBA
04/2023 - 11/2002
8RNA (Ribonucleic Acid)IBA
06/2014 - 06/2002
7Immunoglobulin A (IgA)IBA
12/2023 - 11/2002
6DNA (Deoxyribonucleic Acid)IBA
11/2023 - 06/2002
6Interferon Type IIBA
11/2023 - 06/2010
5Rituximab (Mabthera)FDA Link
11/2020 - 10/2005
5MucinsIBA
10/2018 - 04/2004
5AntigensIBA
07/2018 - 11/2005
5ParaffinIBA
01/2015 - 01/2004
4Immunoglobulins (Immunoglobulin)IBA
11/2022 - 11/2002
4Immunoglobulin G (IgG)IBA
11/2022 - 11/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021 - 01/2004
4eculizumabFDA Link
10/2020 - 11/2013
4Methotrexate (Mexate)FDA LinkGeneric
12/2018 - 08/2005
4Phenobarbital (Luminal)FDA Link
12/2017 - 11/2013
4AutoantibodiesIBA
02/2009 - 01/2003
3InterferonsIBA
02/2024 - 04/2011
3Viral RNAIBA
02/2021 - 06/2020
3Eosine Yellowish-(YS) (Eosin)IBA
02/2021 - 10/2005
3CytokinesIBA
02/2021 - 05/2013
3Interleukin-6 (Interleukin 6)IBA
02/2021 - 01/2017
3Hematoxylin (Haematoxylon)IBA
02/2021 - 10/2005
3Antiphospholipid AntibodiesIBA
01/2021 - 02/2003
3FibrinIBA
12/2017 - 11/2002
3NAD (NADH)IBA
06/2017 - 03/2010
3Formaldehyde (Formol)FDA Link
01/2015 - 01/2005
3Adenylyl Cyclases (Adenylyl Cyclase)IBA
12/2012 - 05/2010
3Tuberculin (PPD)IBA
11/2008 - 08/2007
3anti-endothelial cell antibodyIBA
01/2008 - 06/2006
2Terbinafine (Lamisil)FDA LinkGeneric
06/2023 - 01/2008
2Antigen-Antibody Complex (Immune Complex)IBA
11/2022 - 04/2002
2Hydroxyurea (Hydrea)FDA LinkGeneric
05/2022 - 11/2008
2Capsid Proteins (Capsid Protein)IBA
02/2021 - 12/2020
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020 - 08/2012
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2020 - 04/2002
2LigandsIBA
01/2018 - 05/2013
2GadoliniumIBA
01/2017 - 09/2008

Therapy/Procedure

24Therapeutics
11/2023 - 09/2003
7Drug Therapy (Chemotherapy)
07/2018 - 01/2003
3Renal Dialysis (Hemodialysis)
01/2017 - 06/2003
2Organ Transplantation
12/2018 - 06/2003
2Transplantation
12/2017 - 11/2002